| 2026-08-14 | Press release | PDF Version |
| 2026-08-14 | Press release | Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-08-06 | Press release | Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-08-05 | Presentation | Korro Bio August 2026 Corporate Presentation |
| 2026-07-10 | Press release | Korro Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-06-08 | Presentation | PDF Version |
| 2026-05-27 | Press release | Korro to Present at the 2026 Jefferies Global Healthcare Conference |
| 2026-05-19 | Press release | Korro Selects KRRO-111 as Development Candidate for the Potential Treatment of Alpha-1 Antitrypsin Deficiency (AATD) |
| 2026-05-15 | Press release | Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-05-07 | Presentation | Korro Bio American Society of Gene and Cell Therapy 2026 TDP43 Poster |
| 2026-05-07 | Press release | Korro Reports First Quarter 2026 Financial Results and Provides Corporate Update |
| 2026-05-05 | Press release | Korro to Participate in Upcoming Investor Conferences |
| 2026-04-16 | Press release | Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences |
| 2026-04-10 | Press release | Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 2026-03-12 | Press release | Korro Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update |
| 2026-02-25 | Press release | Korro to Present at the TD Cowen 46th Annual Health Care Conference |
| 2026-01-27 | Presentation | Analyst Day Presentation |
| 2026-01-20 | Press release | Korro to Host Virtual Analyst Day on January 27, 2026 |
| 2026-01-08 | Press release | Korro to Present at the 44th Annual J.P. Morgan Healthcare Conference |
| 2025-09-02 | Press release | Korro to Participate in Upcoming Investor and Scientific Conferences |
| Press release | Korro Reports Second Quarter 2025 Financial Results and Provides Business Updates |
| 2025-07-21 | Press release | Korro Receives European Medicines Agency Orphan Drug Designation for KRRO-110 |
| 2025-05-14 | Press release | Korro to Participate in Upcoming Investor Conferences |
| Press release | Korro Reports First Quarter 2025 Financial Results and Provides Business Updates |
| 2025-03-18 | Press release | PDF Version |
| 2025-03-18 | Press release | Korro Reports Full Year 2024 Financial Results and Provides Business Updates |
| 2025-03-14 | Press release | PDF Version |
| 2025-03-14 | Press release | KRRO-110 Receives Orphan Drug Designation from U.S. FDA for Alpha-1 Antitrypsin Deficiency |
| 2025-02-26 | Press release | PDF Version |
| 2025-02-26 | Press release | Korro to Present at the TD Cowen 45th Annual Health Care Conference |
| 2024-11-12 | Press release | Korro Reports Third Quarter 2024 Financial Results and Provides Business Updates |
| 2024-08-13 | Press release | Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates |
| 2024-05-14 | Press release | Korro Reports First Quarter 2024 Financial Results and Appointment of Kemi Olugemo, M.D. as Chief Medical Officer |
| 2024-03-26 | Press release | Korro Reports Full Year 2023 Financial Results and Highlights Recent Progress |
| 2024-01-04 | Press release | PDF Version |
| 2023-03-07 | Press release | PDF Version |
| 2022-06-06 | Press release | PDF Version |